Digital Versus Digitized: Common Misconceptions About eConsent
With today’s world centered around digital interaction, it may surprise you that a recent Medable poll found the informed consent process remains rooted in paper.
However, this reliance comes at a cost. Low enrolment, poor patient retention and issues around site compliance lead to audits, inspection findings and trial delays.
With Nature stating that almost 60 percent of clinical professionals expect eConsent adoption to continue post-COVID-19, it is clear the benefits behind digital consent have garnered trust.
So, why does adoption continue to increase, albeit slowly?
In this on-demand webinar attendees will learn about the common misconceptions surrounding eConsent, as well as the benefits they can realize through a digitally-enabled approach.
Specifically, you’ll learn:
- The myths that continue to persist around eConsent
- The difference between eConsent and eSignature
- How to improve comprehension with patient-centric consent
- How to use a digital consent management system to improve trial compliance, quality and oversight
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.